Joanna J. Jones

Discovery and optimisation of potent, selective, ethanolamine inhibitors of bacterial phenylalanyl tRNA synthetase.

A. K. Forrest, R. Sheppard, A. Fosberry, 2005, Bioorganic & medicinal chemistry letters.

Type IIA topoisomerase inhibition by a new class of antibacterial agents

Kristin K. Brown, M. Hann, A. Fosberry, 2010, Nature.

Crystal Structure of Human Cytochrome P450 2D6*

Frank E. Blaney, Sandeep Modi, F. Blaney, 2005, Journal of Biological Chemistry.

Exploitation of GFP fusion proteins and stress avoidance as a generic strategy for the production of high-quality recombinant proteins.

Tim W. Overton, C. Hewitt, R. Hall, 2009, FEMS microbiology letters.

Nuclear magnetic resonance spectroscopy reveals the functional state of the signalling protein CheY in vivo in Escherichia coli

A. Fosberry, J. Hubbard, L. K. MacLachlan, 2003, Molecular microbiology.

Purification and Structural Determination of SCB1, a γ-Butyrolactone That Elicits Antibiotic Production inStreptomyces coelicolor A3(2)*

M. Bibb, E. Takano, T. Nihira, 2000, The Journal of Biological Chemistry.

Structural variation and inhibitor binding in polypeptide deformylase from four different bacterial species

M. Lonetto, A. Fosberry, Kathrine J. Smith, 2003, Protein science : a publication of the Protein Society.

Whole Cell Biotransformation of 5‐(4‐(2‐(2‐Pyridyl)methylamino)ethoxy)benzylidenethiazolidine‐2,4‐dione to its Benzyl Derivative Using a Yeast Reductase

M. Verrall, M. Rees, C. M. Heath, 1997 .

Exploitation of GFP fusion proteins and stress avoidance as a generic strategy for the production of high-quality recombinant proteins.

Tim W. Overton, C. Hewitt, R. Hall, 2009, FEMS microbiology letters.